RD

Rekha Devi

Active Director Director DIN 09773430
DIN 09773430 First appointment Oct 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Rekha Devi

Data last updated:

Rekha Devi is a Director at Adveeta Biotech Private Limited (since 2022). The company operates in Healthcare. Adveeta Biotech Private Limited reported revenue of ₹1.30 Cr (FY 2025).

DIN 09773430
Primary Designation Director
Industry Healthcare
First Appointment 21 Oct 2022
Oldest Company Age 4 yrs
Largest company Adveeta Biotech Private Limited · ₹1.30 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adveeta Biotech Private Limited U33110MH2022PTC392601
Director21 Oct 20222022₹1.30 Cr (FY 2025)Active

Board colleagues of Rekha Devi

NameDINCompanyDesignation
Bharat Bhalaram Purohit01015415Adveeta Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adveeta Biotech Private Limited
Premium access

Shareholding and investment profile for Rekha Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Devi

Rekha Devi currently holds 1 directorship: Adveeta Biotech Private Limited (Director, since 21 Oct 2022, revenue ₹1.30 Cr (FY 2025)).

Rekha Devi was first appointed on 21 Oct 2022 as Director at Adveeta Biotech Private Limited.

The current boards of Rekha Devi's companies include Bharat Bhalaram Purohit (Adveeta Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available